- •Chapter 1
- •Ocular Adnexal Lymphoproliferative
- •1.1 Pathogenesis
- •1.2 Chronic Antigen Stimulation
- •1.3 Immunosuppression
- •1.4 Pathology
- •1.5 Cytogenetics
- •1.6 Clinical Features
- •1.7 Imaging Findings
- •1.8 Staging
- •1.9 Positron Emission Tomography
- •1.10 Treatment
- •1.11 Follicular Lymphoma
- •1.12 Mantle Cell Lymphoma
- •1.13 Radiotherapy
- •1.14 Chemotherapy
- •1.15 Immunotherapy
- •1.16 Radioimmunotherapy
- •1.17 Outcome
- •1.18 The Future
- •References
- •Chapter 2
- •2.1 General Introduction
- •2.2 The Aging Process and Facial Analysis
- •2.3 Endoscopic Brow Lift
- •2.3.1 Introduction
- •2.3.2 Endoscopic Browlift Anesthesia Pearls
- •2.3.4 Endoscopic Browlift Postoperative Care Pearls
- •2.4 Upper Blepharoplasty
- •2.4.1 Introduction
- •2.4.2 Patient Evaluation
- •2.4.3 Upper Blepharoplasty Anesthesia Pearls
- •2.4.4 Upper Blepharoplasty Surgical Procedure Pearls
- •2.5 Lower Blepharoplasty, Fillers, and Midface Augmentation
- •2.5.1 Introduction
- •2.5.2 Patient Evaluation
- •2.5.3 Lower Blepharoplasty Anesthesia Pearls
- •2.5.4 Lower Blepharoplasty Surgical Procedure Pearls
- •References
- •Chapter 3
- •3.1 Introduction
- •3.2 What Is the Diagnosis?
- •3.2.1 Pitfalls of Diagnosis
- •3.2.2 A Diagnostic Corticosteroid Trial?
- •3.2.3 The Question of Biopsy
- •3.3 Treatment
- •3.3.1 Corticosteroids
- •3.3.2 Radiation
- •3.3.3 Other Agents
- •3.4 Special Circumstances
- •3.4.1 Pediatric IOIS
- •3.4.2 Sclerosing Pseudotumor
- •3.4.3 Tolosa–Hunt Syndrome
- •References
- •Chapter 4
- •4.1 Introduction
- •4.2 Embryology, Anatomy, Physiology, and Pathophysiology of the Canalicular System
- •4.3 Infective Causes
- •4.3.1 Periocular Herpes Simplex Infection
- •4.3.2 Bacterial Canaliculitis
- •4.4.1 Lichen Planus
- •4.4.2 Ocular Cicatricial Pemphigoid
- •4.5 Iatrogenic Causes
- •4.5.1 Systemic Drugs
- •4.5.1.2 Docetaxel (Taxotere)
- •4.5.2 Radiotherapy
- •4.5.3 Topical Ophthalmic Treatments
- •4.5.3.2 Mitomycin C (MMC) Therapy
- •4.5.4 Lacrimal Stents and Plugs
- •4.6 The Surgical Approach to Managing Canalicular Disease
- •4.6.1 Surgical Technique for Dacryocystorhinostomy with Retrograde Canaliculostomy
- •References
- •Chapter 5
- •5.1 Introduction
- •5.2 Nomenclature
- •5.3 Clinical Manifestations of NF1
- •5.4 Orbitofacial Tumors in NF1
- •5.4.2 Malignant Peripheral Nerve Sheath Tumors
- •5.4.3 Optic Pathway Gliomas
- •5.5 Genetics
- •5.5.1 The NF1 Gene
- •5.5.2 Overlapping NF1-Like Phenotype (SPRED1)
- •5.6.1 Introduction
- •5.7 Surgical Management of Orbitofacial Tumors in NF1
- •5.7.1 Introduction
- •5.7.2 Timing of Surgery
- •5.7.3 Periorbital Involvement
- •5.7.3.1 The Upper Eyelid
- •5.7.3.2 The Lower Eyelid and Midface
- •5.7.4 Orbital Involvement
- •5.7.4.1 Proptosis
- •5.7.4.3 Proptosis Due to Optic Nerve Glioma
- •5.7.4.4 Orbital Enlargement with Dystopia and Hypoglobus
- •5.8 The Natural History of NF1 Tumor Growth from Birth to Senescence
- •References
- •Chapter 6
- •6.1 Introduction
- •6.2 Surgical Anatomy of the Lacrimal Drainage System
- •6.3 Basic Diagnostics for Disorders of the Lacrimal Drainage System
- •6.4 Selective Lacrimal Sac Biopsy in External Dacryocystorhinostomy
- •6.5.1 Case A
- •6.5.2 Case B
- •6.5.3 Case C
- •6.5.4 Case D
- •6.5.5 Case E
- •6.5.6 Case F
- •6.5.7 Case G
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Patients
- •7.2.2 Examination
- •7.3 Results
- •7.3.1 Patient Data
- •7.3.3 Family History
- •7.3.4 Pregnancy History
- •7.3.5 Birth
- •7.3.6 Associated Systemic and Ocular Diseases
- •7.3.8 Neuroradiological Findings (Brain MRI)
- •7.3.9 Nasolacrimal System Findings
- •7.4 Discussion
- •7.4.1 Patients
- •7.4.2 Obstetric and Family History
- •7.4.3 Associated Pathologies
- •7.4.3.1 Ophthalmological Findings in Unilateral Disease
- •7.4.3.2 Neuroradiological Findings
- •7.4.3.3 Systemic Diseases
- •7.4.3.4 Nasolacrimal Duct Findings
- •7.5 Conclusions
- •References
- •Chapter 8
- •8.1 Introduction
- •8.2 Evaluation of Complicated Ptosis
- •8.2.1 Compensatory Eyebrow Elevation
- •8.2.3 Innervation Patterns of the Frontalis Muscle
- •8.2.4 Checklist of Preoperative Evaluation of Complicated Ptosis
- •8.3 Surgical Technique of Levator Muscle Recession
- •8.3.1 Principle
- •8.3.2 Approach to the Levator
- •8.3.3 Partial Levator Recession
- •8.3.4 Total Levator Recession
- •8.3.6 Undercorrection and Overcorrection
- •8.4 Surgical Technique of Brow Suspension
- •8.4.1 Materials for Brow Suspension
- •8.4.1.1 Nonautogenous Materials
- •8.4.1.2 Autogenous Fascia Lata
- •8.4.2 Our Technique of Harvesting Autogenous Fascia Lata
- •8.4.3 Mechanical Principals of Brow Suspension
- •8.4.4 Upper Lid Approach
- •8.4.5 Fascia Implantation
- •References
- •Chapter 9
- •Modern Concepts in Orbital Imaging
- •9.1 Computerized Tomography
- •9.2 Three-Dimensional Imaging
- •9.3 Magnetic Resonance Imaging
- •9.3.1 The T1 Constant
- •9.3.2 The T2 Constant
- •9.3.3 Creating the MR Image
- •9.4 Imaging of Common Orbital Lesions
- •9.4.1 Adenoid Cystic Carcinoma
- •9.4.2 Cavernous Hemangioma
- •9.4.3 Dermoid Cyst
- •9.4.4 Fibrous Dysplasia
- •9.4.5 Lymphangioma
- •9.4.6 Lymphoma
- •9.4.7 Myositis
- •9.4.8 Optic Nerve Glioma
- •9.4.9 Pseudotumor
- •9.4.10 Rhabdomyosarcoma
- •9.6 Positron Emission Tomography
- •9.7 Orbital Ultrasound
- •9.7.1 Physics and Instrumentation
- •9.7.1.1 Topographic Echography
- •9.7.1.2 Quantitative Echography
- •9.7.1.3 Kinetic Echography
- •9.7.2 Extraocular Muscles
- •9.7.3 Optic Nerves
- •References
- •Chapter 10
- •10.1 Introduction
- •10.3 Etiology
- •10.4 Microbiology
- •10.5 Changing Pathogens and Resistance
- •10.5.2 Orbital MRSA
- •10.6 Evaluation of Orbital Cellulitis
- •10.7 Medical Treatment of Orbital Cellulitis
- •10.8 Surgical Treatment of Orbital Cellulitis
- •10.9 Prevention of Orbital Cellulitis After Orbital Fracture
- •References
- •Chapter 11
- •11.1 Clinical Picture
- •11.1.1 Clinical Phases
- •11.2 Ocular Complications
- •11.3 Investigation
- •11.3.1 Angiography
- •11.4 Management
- •11.4.1 Active Nonintervention
- •11.4.2 Indications for Treatment
- •11.5 Modalities of Treatment
- •11.5.1 Steroids
- •11.5.1.1 Topical Steroids
- •11.5.1.2 Intralesional Corticosteroid Injection
- •11.5.1.3 Oral Corticosteroids
- •11.5.2 Interferon-Alfa
- •11.5.3 Vincristine
- •11.5.4 Laser
- •11.5.5 Embolization
- •11.5.6 Surgery
- •References
- •Chapter 12
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3 Biological Behavior and Timing of Metastasis
- •12.4 Lateralization
- •12.5 Localization
- •12.6 Clinical Features
- •12.7 Imaging and Patterns of Orbital Metastatic Disease
- •12.8 Biopsy
- •12.9 Common Types of Orbital Metastases
- •12.9.1 Breast Carcinoma
- •12.9.2 Lung Carcinoma
- •12.9.3 Prostatic Cancer
- •12.9.4 Melanoma
- •12.9.5 Carcinoid Tumor
- •12.11 Treatment
- •12.11.1 Radiotherapy
- •12.11.2 Chemotherapy
- •12.11.3 Hormonal Therapy
- •12.11.4 Surgery
- •12.12 Prognosis and Survival
- •References
- •Chapter 13
- •13.1 Introduction
- •13.2 Rituximab
- •13.3 Yttrium-90-Labeled Ibritumomab Tiuxetan
- •13.4 Imatinib Mesylate
- •13.5 Cetuximab
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Porous Orbital Implants
- •14.3 Orbital Implant Selection in Adults
- •14.4 Orbital Implant Selection in Children
- •14.5 Volume Considerations in Orbital Implant Selection
- •14.7 Which Wrap to Use
- •14.8 To Peg or Not to Peg Porous Implants
- •14.9 Summary
- •References
- •Chapter 15
- •15.1 Introduction
- •15.2 Etiology and Presentation
- •15.2.1 Etiology of Orbital Volume Loss
- •15.2.2 Etiology of Periorbital Volume Loss
- •15.2.3 Features of Orbital Volume Loss
- •15.2.4 Features of Periorbital Volume Loss
- •15.3 Background to Injectable Soft-Tissue Fillers
- •15.3.1 Historical Perspective on Volume Replacement
- •15.4 Types of Injectable Soft-Tissue Filler
- •15.4.1 Collagen Fillers
- •15.4.2 Hyaluronic acid Fillers
- •15.5 Treatment Areas
- •15.5.1 Orbit
- •15.5.2 Upper Eyelid and Brow
- •15.5.3 Tear Trough
- •15.5.4 Temple and Brow
- •15.6 Other Periorbital Uses of Injectable Soft-Tissue Fillers
- •15.6.1 Upper Eyelid Loading
- •15.6.2 Lower Eyelid Elevation
- •15.6.3 Treatment of Cicatricial Ectropion
- •15.7 Future Developments
- •References
their use in compressive spinal cord lesions; as an analogy, similarly they are not recommended for prostatic metastases located in the orbital apex [14, 20, 74, 113].
12.11.4Surgery
Except for exceptional cases of carcinoid and renal cell tumors, surgery is mainly used for diagnostic, rather than therapeutic, purposes since the disease is usually already widespread [39, 59, 75, 111]. Surgery may also have a palliative benefit in those cases in which other treatments have failed.
References 181
survival rate of up to 35%, and cures have been reported [96, 144]. Cutaneous melanoma can have a long latency, up to 46 years [115]. However, once the orbit is involved, the disease progresses rapidly, with a very short life expectancy [53]. Lung cancer has usually a fulminant course, and the survival is commonly less than 6 months [53].
In our series of 80 cases, melanoma also tended to present in a younger age group (mean 54 years) when compared with breast cancer (mean 62 years), carcinoid tumor (mean 63 years), and prostate cancer (mean 70 years) (p < .005) [150].
References
12.12 Prognosis and Survival
The overall survival of patients with orbital metastases is generally limited to less than a year [39, 45, 53, 64, 126]. A specific prognosis is di cult to obtain given the diversity of primary malignancies. In general, the outcome is poor, although multidisciplinary therapy can be palliative, sometimes inducing remissions and even obtaining cures in some exceptional cases [3].
Metastatic breast carcinoma and carcinoid tumors are typically diagnosed long before the patient consults an ophthalmologist, and survival is often measured in years [54]. Thyroid carcinoma also has a longer survival, but its initial diagnosis can be challenging [64,68].Isolated cases of metastatic renal cell carcinoma managed surgically have a 5-year
Summary for the Clinician
■Metastatic orbital disease includes a heterogeneous group of neoplasms with presentation that varies depending on the extent of the disease and the biology of the primary tumor.
■A complete past medical history, a high index of suspicion, and the rapid progression of the symptoms are key in the diagnosis.
■Strabismus, globe displacement, and pain are common features of this entity.
■Investigations include appropriate orbital and systemic imaging, with histologic studies on orbital tissue in most cases.
■A multidisciplinary approach is essential for adequate management in an attempt to preserve vision, relieve pain, and improve the quality of life. Improved survival, and even cure in some cases, may be achieved.
1.Abramson DH, Servodidio CA (1997) Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch Ophthalmol. 115(1):134
2.Agarwala SS, Kirkwood JM (1999) Melanoma: immunotherapeutic approaches. BioDrugs 12(3):193–208
3.Ahmad SM, Esmaeli B (2007) Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol 18(5): 405–413
4.Albert DM, Rubenstein RA, Scheie HG (1967) Tumor metastasis to the eye. I. Incidence in 213 adult patients with generalized malignancy. Am J Ophthalmol 63(4):723–726
5.Albert DM, Rubenstein RA, Scheie HG (1967) Tumor metastasis to the eye. II. Clinical study in infants and children. Am J Ophthalmol 63(4):727–732
6.Arora R, Rewari R, Betharia SM (1992) Fine needle aspiration cytology of orbital and adnexal masses. Acta Cytol 36(4):483–491
7.Baek CH, Chung MK, Jeong HS, Son YI, Choi J, Kim YD, et al (2009) The clinical usefulness of (18)F-FDG PET/CT for the evaluation of lymph node metastasis in periorbital malignancies. Korean J Radiol 10(1):1–7
8.Ballinger WH Jr., Wesley RE (1984) Seminoma metastatic to the orbit. Ophthalmic Surg 15(2):120–121
9.Bar-Shalom R, Valdivia AY, Blaufox MD (2000) PET imaging in oncology. Semin Nucl Med 30(3):150–185
10.Baston O (1940) The function of the vertebral veins and their role in spread of metastasis. Ann Surg 112:138–149
11.Bernstein-Lipschitz L, Lahav M, Chen V, Gutman I, Gal R, Lipschitz M (1990) Metastatic thyroid carcinoma masquerading as lacrimal gland tumor. Graefes Arch Clin Exp Ophthalmol 228(2):112–115
12.Berquist TH, Bailey PB, Cortese DA, Miller WE (1980) Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo Clin Proc 55(8):475–481
13.Bloch RS, Gartner S (1971) The incidence of ocular metastatic carcinoma. Arch Ophthalmol 85(6):673–675
18212 Evaluation and Management of Metastatic Orbital Tumors
14.Boldt HC, Nerad JA (1988) Orbital metastases from pros34. Ewers SB, Langstrom E, Baldetorp B, Killander D (1984)
tate carcinoma. Arch Ophthalmol 106(10):1403–1408
15.Bowling BS, Damato BE, Foy PM (1994) Choroidal melanoma metastatic to the contralateral orbit: implications for
12 |
patient management. Eye 8:(Pt 1):144–145 |
16.Bullock JD, Yanes B (1980) Metastatic tumors of the orbit. Ann Ophthalmol 12(12):1392–1394
17.Bullock JD, Yanes B (1980) Ophthalmic manifestations of metastatic breast cancer. Ophthalmology 87(10):961–973
18.Bullock JD, Straughen WJ (1981) Carcinoma of the common bile duct metastatic to the orbit. Ann Ophthalmol 13(5):619–621
19.Burch FE (1932) Orbital metastases from malignant tumors of the suprerenal gland. Arch Ophthalmol 7:418–433
20.Carriere VM, Karcioglu ZA, Apple DJ, Insler MS (1982) A case of prostate carcinoma with bilateral orbital metastases and the review of the literature. Ophthalmology 89(4): 402–406
21.Castro PA, Albert DM, Wang WJ, Ni C (1982) Tumors metastatic to the eye and adnexa. Int Ophthalmol Clin 22(3):189–223
22.Char DH, Miller T, Kroll S (1997) Orbital metastases: diagnosis and course. Br J Ophthalmol 81(5):386–390
23.Cline RA, Rootman J (1984) Enophthalmos: a clinical review. Ophthalmology 91(3):229–237
24.Collins MJ, Wojno TH, Grossniklaus HE (1999) Metastatic esophageal carcinoma to the orbit. Am J Ophthalmol 127(2):228–229
25.Colombel M (2008) Prescription of bisphosphonates in prostate cancer. Prog Urol 18(1 Suppl FMC):F5–7
26.Czerniak B,Woyke S, Daniel B,Krzysztolik Z, Koss LG (1984) Diagnosis of orbital tumors by aspiration biopsy guided by computerized tomography. Cancer 54(11):2385–2389
27.Denby P, Harvey L, English MG (1986) Solitary metastasis from an occult renal cell carcinoma presenting as a primary lacrimal gland tumor. Orbit (5):21–24
28.di Sant’Agnese PA (1992) Neuroendocrine di erentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer 70(1 Suppl):254–268
29.Dieckert JP, Berger BB (1982) Prostatic carcinoma metastatic to choroid. Br J Ophthalmol 66(4):234–239
30.Dieing A, Schulz CO, Schmid P, Roever AC, LehenbauerDehm S, Jehn C, et al (2004) Orbital metastases in breast cancer: report of two cases and review of the literature. J Cancer Res Clin Oncol 130(12):745–748
31.Divine RD, Anderson RL, Ossoinig KC (1982) Metastatic carcinoid unresponsive to radiation therapy presenting as a lacrimal fossa mass. Ophthalmology 89(5):516–520
32.Divine RD, Anderson RL (1982) Metastatic small cell carcinoma masquerading as orbital myositis. Ophthalmic Surg 13(6):483–487
33.Dresner SC, Kennerdell JS, Dekker A (1983) Fine needle aspiration biopsy of metastatic orbital tumors. Surv Ophthalmol 27(6):397–398
Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5(4): 408–419
35.Fan JT, Buettner H, Bartley GB, Bolling JP (1995) Clinical features and treatment of seven patients with carcinoid tumor metastatic to the eye and orbit. Am J Ophthalmol 119(2):211–218
36.Ferry AP (1978) Tumors metastatic to the eye and ocular adnexa. In: Jakobiec FA (ed) Ocular and adnexal tumors. Aesculapius, Birmingham, pp 862–892
37.Fezza J, Sinard J (1997) Metastatic liposarcoma to the orbit. Am J Ophthalmol 123(2):271–272
38.Font RL, Naumann G, Zimmerman LE (1964) Primary malignant melanoma of the skin metastatic to the eye and orbit. Am J Ophthalmol 63:738–754
39.Font RL, Ferry AP (1976) Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer 38(3):1326–1335
40.Font RL, Maturi RK, Small RG, Garcia-Rojas M (1998) Hepatocellular carcinoma metastatic to the orbit. Arch Ophthalmol 116(7):942–945
41.Forrest AW (1949) Intraorbital tumors. Arch Ophthal 41(2):198–232
42.Fred W, VG C (1993) Gastric carcinoma metastases to extraoculant muscles. J Comput Assist Tomogr 17:499–500
43.Frederiksen PL, Engelholm A, Mouridsen HT (1978) Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen. Ugeskr Laeger 140(43):2639–2641
44.Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT (1978) Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Cancer Treat Rep 62(3):449–450
45.Freedman MI, Folk JC (1987) Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol 105(9):1215–1219
46.Friedlander ML, Hedley DW, Taylor IW, Russell P, Coates AS, Tattersall MH (1984) Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 44(1):397–400
47.Garcia GH, Weinberg DA, Glasgow BJ, Hunt KE, Venegas R, Goldberg RA (1998) Carcinoma of the male breast metastatic to both orbits. Ophthal Plast Reconstr Surg 14(2):130–133
48.Garrity JA, Henderson JW, Cameron JD (2007) Metastatic carcinomas. In: Garrity JA, Henderson JW, Cameron JD, Henderson’s orbital tumors, 4th ed. Raven Press, New York, pp 313–326
49.Geetha N, Chandralekha B, Kumar A, Ittiyavirah AK, Ramadas K, Joseph F (1998) Carcinoma of the pancreas presenting as an orbital tumor: a case report. Am J Clin Oncol 21(5):532–533
References 183
50.Giordano GG (1995) Orbital metastasis from a urachal tumor. Arch Ophthalmol 113(4):413–415
51.Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678–687
52.Glassburn JR, Klionsky M, Brady LW (1984) Radiation therapy for metastatic disease involving the orbit. Am J Clin Oncol 7(2):145–148
53.Goldberg RA, Rootman J, Cline RA (1990) Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol 35(1):1–24
54.Goldberg RA, Rootman J (1990) Clinical characteristics of metastatic orbital tumors. Ophthalmology 97(5):620–624
55.Goldberg SH, Kennedy RE, Metz HS, Searl SS, Rose SJ (1990) Strabismus caused by melanoma metastatic to an extraocular muscle. Ann Ophthalmol 22(12):467–471
56.Green JR (2005) Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates. Acta Oncol 44(3):282–292
57.Gunalp I, Gunduz K (1995) Metastatic orbital tumors. Jpn J Ophthalmol 39(1):65–70
58.Gupta R, Honavar SG, Vemuganti GK (2005) Orbital metastasis from hepatocellular carcinoma. Surv Ophthalmol 50(5):485–489
59.Harris AL, Montgomery A (1980) Orbital carcinoid tumor. Am J Ophthalmol 90(6):875–877
60.Harris AL, Montgomery A, Reyes RR, Gazet JC, Smith IE (1981) Carcinoid tumour presenting as an orbital metastasis. Clin Oncol 7(4):365–372
61.Hart W (1962) Metastatic carcinoma to the eye and orbit. Int Ophthalmol Clin 2:465–482
62.Hart W (1962) Metastatic tumors of the eye and orbit. Int Ophthalmol Clin 2:465–482
63.Healy JF (1983) Computed tomographic evaluation of metastases to the orbit. Ann Ophthalmol 15(11):1026–1029
64.Henderson J, Farrow GM (1980) Metastatic carcinoma. In: Henderson J (ed) Orbital tumors. Decker, New York, pp 451–471
65.Henderson JWCR, Farrow GM (1994) Metastatic carcinomas. New York, Raven Press
66.Hesselink JR, Davis KR, Weber AL, Davis JM, Taveras JM (1980) Radiological evaluation of orbital metastases, with emphasis on computed tomography. Radiology 137(2): 363–366
67.Holt BAU,Holmes SAV,Kirby RS (1994) Renal cell carcinoma presenting with orbital metastasis. Br J Urol 75: 246–247
68.Hornblass A, Kass LG, Reich R (1987) Thyroid carcinoma metastatic to the orbit. Ophthalmology 94(8):1004–1007
69.Horner F (1864) Carcino der Dura mater. Klin Monatsbl Augenheilkd 2:186–190
70.Horwitz KB, Costlow ME, McGuire WL (1975) MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 26(6): 785–795
71.Horwitz KB, McGuire WL (1975) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189(4204):726–727
72.Horwitz KB, McGuire WL (1975) Specific progesterone receptors in human breast cancer. Steroids 25(4):497–505
73.Houghton JD (1956) Solitary metastasis of renal cell carcinoma. Am J Ophthalmol (41):548–549
74.Huben RP, Murphy GP (1986) Prostate cancer: an update. CA Cancer J Clin 36(5):274–292
75.Huh SH, Nisce LZ, Simpson LD, Chu FC (1974) Proceedings: value of radiation therapy in the treatment of orbital metastasis. Am J Roentgenol Radium Ther Nucl Med 120(3):589–594
76.Hutchison DS, Smith TR (1979) Ocular and orbital metastatic carcinoma. Ann Ophthalmol 11(6):869–873
77.Ives NJ, Stowe RL, Lorigan P, Wheatley K (2007) Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol 25(34): 5426–5434
78.Jensen OA (1970) Metastatic tumours of the eye and orbit. A histopathological analysis of a Danish series. Acta Pathol Microbiol Scand 212(Suppl):201–214
79.Kawaoka T, Aikata H, Takaki S, Uka K, Azakami T Saneto H, et al (2009) FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatol Res 39(2): 134–142
80.Kennedy RE (1984) An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc 82:134–157
81.Kennerdell JS, Dekker A, Johnson BL, Dubois PJ (1979) Fine-needle aspiration biopsy. Its use in orbital tumors. Arch Ophthalmol 97(7):1315–1317
82.Kennerdell JS, Maroon JC, Dekker A, Johnson BL (1979) Microsurgery and fine needle aspiration biopsy of orbital tumors. Trans Pa Acad Ophthalmol Otolaryngol 32(2): 147–150
83.Kimura N, Pilichowska M, Okamoto H, Kimura I, Aunis D (2000) Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol 13(2):140–146
84.Koelma IA, Nap M, Huitema S, Krom RA, Houtho HJ (1986) Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 110(11):1035–1040
85.Kokal WA, Gardine RL, Sheibani K, Morris PL, Prager E, Zak IW, et al (1989) Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 209(2): 188–193
86.Kuzma BB, Goodman JM (1998) Slowly progressive bilateral enophthalmos from metastatic breast carcinoma. Surg Neurol 50(6):600–602
184 |
12 Evaluation and Management of Metastatic Orbital Tumors |
87.Lacreusette A, Lartigue A, Nguyen JM, Barbieux I, Pandolfino MC, Paris F, et al (2008) Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with
12 |
tumour-infiltrating lymphocytes. J Pathol 216(4):451–459 |
88.Lee HM, Choo CT, Poh WT (1997) Orbital metastasis from carcinoma of cervix. Br J Ophthalmol 81(4): 330–331
89.Liu D (1985) Complications of fine needle aspiration biopsy of the orbit. Ophthalmology 92(12):1768–1771
90.Lubin JR, Grove AS Jr., Zakov ZN, Albert DM (1980) Hepatoma metastatic to the orbit. Am J Ophthalmol 89(2):268–273
91.Macedo JE, Machado M, Araujo A, Angelico V, Lopes JM (2007) Orbital metastasis as a rare form of clinical presentation of non-small cell lung cancer. J Thorac Oncol 2(2): 166–167
92.Margo CE, Levy MH (1993) Orbital metastasis from medullary carcinoma of the thyroid. Am J Ophthalmol 115(3): 394–395
93.Martin RG (1970) Management of carcinoid tumors. Cancer 26(3):547–551
94.McGuire WL (1975) Quantitation of estrogen receptor in mammary carcinoma. Methods Enzymol 36(00): 248–254
95.Mehta JS, Abou-Rayyah Y, Rose GE (2006) Orbital carcinoid metastases. Ophthalmology 113(3):466–472
96.Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97(6):973–977
97.Mitchell ME, Johnson JA, Wilton PB (1996) Five primary
synchronous neoplasms of the gastrointestinal tract. J Clin Gastroenterol 23(4):284–288
98.Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959
99.Moschos SJ, Mandic M, Kirkwood JM, Storkus WJ, Lotze MT (2008) Focus on FOCIS: interleukin 2 treatment associated autoimmunity. Clin Immunol 127(2): 123–129
100.Moss HM (1962) Expanding lesions of the orbit. A clinical study of 230 consecutive cases. Am J Ophthalmol 54: 761–770
101.Mottow-Lippa L, Jakobiec FA, Iwamoto T (1981) Pseudoinflammatory metastatic breast carcinoma of the orbit and lids. Ophthalmology 88(6):575–580
102.Mouridsen H, Palshof T, Patterson J, Battersby L (1978) Tamoxifen in advanced breast cancer. Cancer Treat Rev 5(3):131–141
103.Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al (2009) Integrated FDG-PET/ CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med 23(1):73–80
104.Perez-Fidalgo JA, Oltra Ferrando A, Lopez Jimenez A, Maestu Maiques I (2006) Primary carcinoid tumour of the pancreas. Clin Transl Oncol 8(1):54–56
105.Po SM, Custer PL, Smith ME (1996) Bilateral lagophthalmos. An unusual presentation of metastatic breast carcinoma. Arch Ophthalmol 114(9):1139–1141
106.Poli T, Mora P, Reichegger V, Ricci R, Corradi D, Gandolfi SA, et al (2007) Surgical management of orbital malignant melanoma: our experience and a report of three cases. Klin Monatsbl Augenheilkd 224(10):794–798
107.Recchia F, Candeloro G, Necozione S, Fumagalli L, Bratta M, Rea S (2008) Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma. Anticancer Drugs 19(2):201–207
108.Reese AB (1971) Expanding lesions of the orbit. Trans Ophthalmol Soc U K 91:85–104
109.Reifler DM, Kini SR, Liu D, Littleton RH (1984) Orbital metastasis from prostatic carcinoma. Identification by immunocytology. Arch Ophthalmol 102(2):292–295
110.Reifler DM (1985) Orbital metastasis with enophthalmos: a review of the literature. Henry Ford Hosp Med J 33(4): 171–179
111.Riddle PJ, Font RL, Zimmerman LE (1982) Carcinoid tumors of the eye and orbit: a clinicopathologic study of 15 cases, with histochemical and electron microscopic observations. Hum Pathol 13(5):459–469
112.Roato I, D’Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, et al (2008) Osteoclasts are active in bone forming metastases of prostate cancer patients. PLoS One 3(11):e3627
113.Rootman J, Ragaz J, Cline R, Lapointe J (1988) In: Rootman J (ed) Diseases of the orbit. Lippincott, Philadelphia, pp 405–457
114.Rosenbluth J, Laval J, Weil JV (1960) Metastasis of bronchial adenoma to the eye. Arch Ophthalmol 63:47–50
115.Rosenkranz L, Schroeder C (1985) Recurrent malignant melanoma following a 46-year disease-free interval. N Y State J Med 85(3):95
116.Rothfus WE, Curtin HD (1984) Extraocular muscle enlargement: a CT review. Radiology 151(3):677–681
117.Rush JA, Waller RR, Campbell RJ (1980) Orbital carcinoid tumor metastatic from the colon. Am J Ophthalmol 89(5):636–640
118.Rush JA, Older JJ (1987) Testicular seminoma metastatic to the orbit. Am J Ophthalmol 104:634–640
119.Sanders RJ, Axtell HK (1964) Carcinoids of the gastrointestinal tract. Surg Gynecol Obstet 119:369–380
120.Schwab L, Doshi H, Shields JA, Kagame K, Chana H (1994) Hepatocellular carcinoma metastatic to the orbit in an African patient. Ophthalmic Surg 25(2):105–106
121.Seregard S, Sahlin S (1999) Panorama of orbital spaceoccupying lesions. The 24-year experience of a referral centre. Acta Ophthalmol Scand 77(1):91–98
References 185
122.Seretan EL (1981) Metastatic adenocarcinoma from the stomach to the orbit. Arch Ophthalmol 99(8):1469
123.Shah NA, Urusova IA, D’Agnolo A, Colquhoun SD, Rosenbloom BE, Vener SL, et al (2007) Primary hepatic carcinoid tumor presenting as Cushing’s syndrome. J Endocrinol Invest 30(4):327–333
124.Shetlar DJ, Font RL, Ordonez N, el-Naggar A, Boniuk MA (1990) Clinicopathologic study of three carcinoid tumors metastatic to the orbit. Immunohistochemical, ultrastructural, and DNA flow cytometric studies. Ophthalmology 97(2):257–264
125.Shields CL, Shields JA, Eagle RC Jr., Peyster RG, Conner BE, Green HA (1987) Orbital metastasis from a carcinoid tumor. Computed tomography, magnetic resonance imaging, and electron microscopic findings. Arch Ophthalmol 105(7):968–971
126.Shields CL, Shields JA, Peggs M (1988) Tumors metastatic to the orbit. Ophthal Plast Reconstr Surg 4(2):73–80
127.Shields CL,Shields JA,MruczekAW (1989) Enophthalmos as the initial manifestation of metastasis from scirrhous carcinoma of the breast. Ophthal Practice 7:159–160
128.Shields CL, Stopyra GA, Marr BP, Moster ML, Shields JA (2004) Enophthalmos as initial manifestation of occult, mammogram-negative carcinoma of the breast. Ophthalmic Surg Lasers Imaging 35(1):56–57
129.Shields JA, Bakewell B, Augsburger JJ, Flanagan JC (1984) Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Arch Ophthalmol 102(11):1606–1611
130.Shields JA, Shields CL, Shakin EP, Kobetz LE (1988) Metastasis of choroidal melanoma to the contralateral choroid, orbit, and eyelid. Br J Ophthalmol 72(6):456–460
131.Shields JA, Shields CL, Eagle RC Jr., Gunduz K, Lin B (1998) Di use ocular metastases as an initial sign of metastatic lung cancer. Ophthalmic Surg Lasers 29(7):598–601
132.Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle RC Jr (2001) Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg 17(5):346–354
133.Shields JA, Perez N, Shields CL, Singh AD, Eagle RC Jr (2002) Orbital melanoma metastatic from contralateral choroid: management by complete surgical resection. Ophthalmic Surg Lasers 33(5):416–420
134.Shih CY, Mirchandani G, Kazim M (2007) Atypical MRI features of intraorbital metastatic melanoma. Ophthal Plast Reconstr Surg 23(4):335–336
135.Silva D (1968) Orbital tumors. Am J Ophthalmol 65(3):318–339
136.Singer MA, Warren F, Accardi F, Sabatini M, D’Amico RA (1990) Adenocarcinoma of the stomach confirmed by orbital biopsy in a patient seropositive for human immunodeficiency virus. Am J Ophthalmol 110(6):707–709
137.Slamovits TL, Burde RM (1988) Bumpy muscles. Surv Ophthalmol 33(3):189–199
138.Stewart WB, Newman NM, Cavender JC, Spencer WH (1978) Fibrous histiocytoma metastatic to the orbit. Arch Ophthalmol 96(5):871–873
139.Stockl FA, Tucker N, Burnier MN (1997) Thymic carcinoma metastatic to the orbit. Am J Ophthalmol 124(3):401–403
140.Sullivan TJ, Valenzuela AA (2006) Imaging features of ocular adnexal lymphoproliferative disease. Eye 20(10): 1189–1195
141.Thomas KM, Cumberworth VL, McEwan J (1995) Orbital and skin metastases in a polymorphous low grade adenocarcinoma of the salivary gland. J Laryngol Otol 109(12):1222–1225
142.Tijl JW, Koornneef L (1991) Fine needle aspiration biopsy in orbital tumours. Br J Ophthalmol 75(8):491–4 92
143.Tijl J, Koornneef L, Eijpe A, Thomas L, Gonzalez DG, Veenhof C (1992) Metastatic tumors to the orbit—man- agement and prognosis. Graefes Arch Clin Exp Ophthalmol 230(6):527–530
144.Tolia BM, Whitmore WF Jr (1975) Solitary metastasis from renal cell carcinoma. J Urol 114(6):836–838
145.Toller KK, Gigantelli JW, Spalding MJ (1998) Bilateral orbital metastases from breast carcinoma. A case of false pseudotumor. Ophthalmology 105(10):1897–901
146.Torres JJ, Medel R, Alonso T, Morral M, Garcia-Arumi J, Myint S,et al (2007) Orbital metastases from male breast cancer in two cases. Ophthal Plast Reconstr Surg 23(2):154–156
147.Tranfa F, Cennamo G, Rosa N, De Rosa G, Boscaino A, Bonavolonta G (1994) An unusual orbital lesion: hepatoma metastatic to the orbit. Ophthalmologica 208(6): 329–332
148.Trokel SL, Hilal SK (1979) Recognition and di erential diagnosis of enlarged extraocular muscles in computed tomography. Am J Ophthalmol 87(4):503–512
149.Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ (2006) Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology 113:2331–2337
150.Valenzuela AA, Archibald CW, Fleming B, Ong L, O’Donnell B, Crompton J, Selva D, McNab AA, Sullivan TJ (2009) Orbital metastases: clinical features, management and outcome. Orbit 28(2):153–159
151.Walton RC, Ellis GS Jr., Haik BG (1996) Rhabdomyosarcoma presumed metastatic to the orbit. Ophthalmology 103(9):1512–1516
152.Warburg O (1931) The metabolism of tumors. Smith RR, New York
153.Weber G (1983) Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes memorial lecture. Cancer Res 43(8):3466–3492
186 |
12 Evaluation and Management of Metastatic Orbital Tumors |
154.Weijerman PC, Boeve ER, Mickisch GH, Simonsz HJ, Schroder FH (1997) Orbital tumours as a first indication of urological malignancies. Br J Urol 79(2):288–289
155.Whyte AM (1978) Bronchogenic carcinoma metastasiz-
12 |
ing to the orbit. A case report. J Maxillofac Surg |
|
6(4):277–280 |
156.Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW (2006) In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit. J Craniomaxillofac Surg 34(1):9–16
157.Winkler CF, Goodman GK, Eiferman RA, Yam LT (1981) Orbitalmetastasisfromprostaticcarcinoma.Identification by an immunoperoxidase technique. Arch Ophthalmol 99(8):1406–1408
158.Wolin MJ (1993) Metastatic renal cell carcinoma manifesting as an orbital mass. Am J Ophthalmol 115(4): 542–543
159.Yang K, Ulich T, Cheng L, Lewin KJ (1983) The neuroendocrine products of intestinal carcinoids. An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones. Cancer 51(10):1918–1926
160.Zajdela A, Vielh P, Schlienger P, Haye C (1990) Fineneedle cytology of 292 palpable orbital and eyelid tumors. Am J Clin Pathol 93(1):100–104
161.Zambarakji HJ, Simcock PR, Kinnear PE (1997) Bilateral orbital metastases in a woman with breast carcinoma. J R Soc Med 90(12):684
162.Zografos L, Ducrey N, Beati D, Schalenbourg A, Spahn B, Balmer A, et al (2003) Metastatic melanoma in the eye and orbit. Ophthalmology 110(11):2245–2256
